SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks ilaris for rare fever diseases in kids and adults
Disease control Recruiting nowThis study watches how well the drug Ilaris works and how safe it is for children and adults with rare hereditary fever syndromes (like CAPS, FMF, TRAPS, HIDS/MKD) and a type of childhood arthritis called sJIA. About 25 people will be followed during their regular treatment. The …
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
Gentler transplant prep offers hope for young patients with rare blood disorders
Disease control Recruiting nowThis study is for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies or inherited anemias. It tests a milder chemotherapy regimen before a stem cell transplant to see if it reduces serious side effects and deaths while still helping…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 11, 2026 20:51 UTC